We compared brain natriuretic peptide (BNP) levels in patients with obstructive sleep
apnea (OSA) with and without cardiovascular disease to BNP in healthy control subjects.
OSA was not associated with increased plasma BNP or atrial natriuretic peptide (ANP)
in otherwise healthy subjects during wakefulness. Untreated OSA increased ANP overnight,
and ANP levels decreased with treatment of OSA. However, OSA did not elicit acute
overnight changes in BNP, either in normal subjects or in patients with coexisting
cardiovascular disease (including chronic heart failure).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.J Sleep Res. 1998; 7: 199-207
- Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea.Am J Hypertens. 2003; 16: 274-280
- Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.JAMA. 2000; 283: 1829-1836
- The occurrence of sleep-disordered breathing among middle-aged adults.N Engl J Med. 1993; 328: 1230-1235
- Sympathetic neural mechanisms in obstructive sleep apnea.J Clin Invest. 1995; 96: 1897-1904
- Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.Am J Respir Crit Care Med. 2002; 165: 934-939
- Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome.Respiration. 1992; 59: 164-168
- Reduced stroke volume related to pleural pressure in obstructive sleep apnea.J Appl Physiol. 1983; 55: 1718-1724
- High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs.Congest Heart Fail. 2003; 9: 127-132
- Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.Endocrinology. 1993; 132: 1961-1970
- Sleep apnea and heart failure. Part I: obstructive sleep apnea.Circulation. 2003; 107: 1671-1678
- Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction.Chest. 2002; 121: 422-429
- Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population.J Hypertens. 2001; 19: 2071-2078
- Effect of intrathoracic pressure on left ventricular performance.N Engl J Med. 1979; 301: 453-459
- Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.J Clin Endocrinol Metab. 1993; 76: 91-96
- Increased human brain natriuretic peptide in congestive heart failure.N Engl J Med. 1990; 323: 757-758
- Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.JAMA. 2002; 288: 1252-1259
- Natriuretic peptide system in human heart failure.Circulation. 1993; 88: 1004-1009
- B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.Circulation. 2003; 107: 2786-2792
- Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study.Hypertension. 2003; 41: 978-983
Article info
Publication history
Accepted:
May 3,
2004
Received:
February 4,
2004
Footnotes
This study was supported by Grants HL-65176, HL-61560, HL-70602, and M01-RR00585 from the National Institutes of Health, Bethesda, Maryland.
Identification
Copyright
© 2004 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
